Genome-wide association studies (GWAS) have linked the locus encoding ankyrin repeat domain 55 (ANKRD55) with numerous autoimmune diseases; however, its biological function and role in inflammation are unclear. Here, we demonstrate that Ankrd55-deficient mice are protected from T cell–mediated colitis but are more susceptible to Citrobacter rodentium infection. Mechanistically, Ankrd55 deletion impairs CD4+ T cell proliferation and reduces effector cytokine production in T helper 17 (TH17) cells in a cell-intrinsic manner. ANKRD55 is associated with mitochondria, and its loss is associated with impaired mitochondrial respiration and activation of the LKB1 pathway. Consistently, IL-17 production can be rescued by the deletion of LKB1 in Ankrd55-deficient T cells. Altogether, our study implicates the protein ANKRD55 as a functional modulator of T cell metabolism that directly impacts TH17 responses, highlighting it as a potential target across multiple autoimmune diseases.
Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation
Disclosures: M.J. Daly reported personal fees from Maze Therapeutics outside the submitted work. A.K. Shalek reported consultation and/or scientific advisory board membership from Honeycomb Biotechnologies, Cellarity, Ochre Bio, Relation Therapeutics, Parabilis Medicines, Quotient Therapeutics, Passkey Therapeutics, Passkey Therapeutics, JNJ, IntrECate Biotherapeutics, Bio-Rad Laboratories, and Dahlia Biosciences, all of which are unrelated to this work. J. Deguine reported personal fees from BioRender, Inc. outside the submitted work. R.J. Xavier is a cofounder of Jnana Therapeutics and Convergence Bio, scientific advisory board member at Nestlé, Magnet BioMedicine, and Arena BioWorks, and board director at MoonLake Immunotherapeutics. M.J. Daly is a cofounder of Maze Therapeutics. These organizations had no roles in this study. No other disclosures were reported.
- Award Id(s): DK043351,DK135492
- Award Id(s): U2C-DK119886
- Award Id(s): 3OT2OD030544
- Award Id(s): 1U2C-DK119889
Jinjin Xu, Lingjia Kong, Elizabeth A. Creasey, Sneha Rath, Lei Deng, Julian Avila-Pacheco, Chenhao Li, Blayne A. Oliver, Tyler T. Dao, Angela R. Shih, Mark J. Daly, Alex K. Shalek, Clary B. Clish, Daniel B. Graham, Jacques Deguine, Ramnik J. Xavier; Autoimmune disease risk gene ANKRD55 promotes TH17 effector function through metabolic modulation. J Exp Med 3 November 2025; 222 (11): e20250185. doi: https://doi.org/10.1084/jem.20250185
Download citation file:
Sign in
Client Account
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement